The neural substrates of the unconditioned and conditioned components of amphetamine (AMPH)-induced behavioral sensitization remain unknown. The present study examines the brain activation of rats in response to an AMPH challenge with augmented locomotion in groups receiving chronic AMPH under chloral hydrate anesthetization (i.e., the ‘zero context’) or when tested in the ‘same context’ as a chronic treatment, or when tested in a ‘different context’. The neural activations of the three groups reveal fairly consistent patterns: (a) The substantia nigra is activated in the same context condition and the pure AMPH effect (i.e., the zero context with the unconditioned component), but not in the switch context condition. (b) The ventral pallidum showed Fos expression in the switch context and the same context, but not in the zero context condition. (c) The other nuclei, including the medial prefrontal cortex, nucleus accumbens, caudate putamen, medial thalamus, hippocampus, amygdala, and ventral tegmental area, are activated in all contextual conditions and the pure AMPH effect (the zero context). The context exerts definable effects on the mesocorticolimbic dopamine system on AMPH-induced behavioral sensitization. (d) The ventral pallidum and the substantia nigra activations dissociate the unconditioned component from the conditioned component in behavioral sensitization. Further studies are needed to determine how these two nuclei mediate the effect in terms of primary and conditioned rewards.

Keywords:
Amphetamine sensitization, Context, Mesocorticolimbic dopamine system, c-fos expression
1.
Anagnostaras SG, Robinson TE: Sensitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning. Behav Neurosci 1996;110:1397–1414.
2.
Robinson TE, Becker JB: Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986;396:157–198.
3.
Crawford CA, Choi FY, Kohutek JL, Yoshida ST, McDougall SA: Changes in PKA activity and Gs alpha and Golf alpha levels after amphetamine- and cocaine-induced behavioral sensitization. Synapse 2004;51:241–248.
4.
Koeltzow TE, Austin JD, Vezina P: Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow. Neuropharmacology 2003;44:102–110.
5.
Anderson SM, Pierce RC: Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol Ther 2005;106:389–403.
6.
See RE: Neural substrates of conditioned-cued relapse to drug-seeking behavior. Pharmacol Biochem Behav 2002;71:517–529.
7.
Self DW, Genova LM, Hope BT, Barnhart WJ, Spencer JJ, Nestler EJ: Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci 1998;18:1848–1859.
8.
Anagnostaras SG, Schallert T, Robinson TE: Memory processes governing amphetamine-induced psychomotor sensitization. Neuropsychopharmacology 2002;26:703–715.
9.
Ohmori T, Abekawa T, Ito K, Koyama T: Context determines the type of sensitized behaviour: a brief review and a hypothesis on the role of environment in behavioural sensitization. Behav Pharmacol 2000;11:211–221.
10.
Browman KE, Badiani A, Robinson TE: Modulatory effect of environmental stimuli on the susceptibility to amphetamine sensitization: a dose-effect study in rats. J Pharmacol Exp Ther 1998;287:1007–1014.
11.
Browman KE, Badiani A, Robinson TE: The influence of environment on the induction of sensitization to the psychomotor activating effects of intravenous cocaine in rats is dose-dependent. Psychopharmacology (Berl) 1998;137:90–98.
12.
Lodge DJ, Grace AA: Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: a mechanism of behavioral sensitization. J Neurosci 2008;28:7876–7882.
13.
Yokel RA, Wise RA: Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 1975;187:547–549.
14.
Robinson TE, Berridge KC: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 1993;18:247–291.
15.
Wise RA: Forebrain substrates of reward and motivation. J Comp Neurol 2005;493:115–121.
16.
Lin SK, Pan WH, Yeh PH: Prefrontal dopamine efflux during exposure to drug-associated contextual cues in rats with prior repeated methamphetamine. Brain Res Bull 2007;71:365–371.
17.
McDougall SA, Reichel CM, Cyr MC, Karper PE, Nazarian A, Crawford CA: Importance of D(1) receptors for associative components of amphetamine-induced behavioral sensitization and conditioned activity: a study using D(1) receptor knockout mice. Psychopharmacology (Berl) 2005;183:20–30.
18.
Deutch AY, Bubser M, Young CD: Psychostimulant-induced Fos protein expression in the thalamic paraventricular nucleus. J Neurosci 1998;18:10680–10687.
19.
Robinson TE, Becker JB: Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur J Pharmacol 1982;85:253–254.
20.
Johansson B, Lindstrom K, Fredholm BB: Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 1994;59:837–849.
21.
Rademacher DJ, Napier TC, Meredith GE: Context modulates the expression of conditioned motor sensitization, cellular activation and synaptophysin immunoreactivity. Eur J Neurosci 2007;26:2661–2668.
22.
Subramaniam S, Marcotte ER, Srivastava LK: Differential changes in synaptic terminal protein expression between nucleus accumbens core and shell in the amphetamine-sensitized rat. Brain Res 2001;901:175–183.
23.
Robinson TE, Kolb B: Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 1999;11:1598–1604.
24.
Pierce RC, Kalivas PW: A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 1997;25:192–216.
25.
Wang YC, Hsiao S: Amphetamine sensitization: nonassociative and associative components. Behav Neurosci 2003;117:961–969.
26.
Pan WH, Lai YJ, Chen NH: Differential effects of chloral hydrate and pentobarbital sodium on a cocaine level and its catecholamine response in the medial prefrontal cortex: a comparison with conscious rats. J Neurochem 1995;64:2653–2659.
27.
Wang YC, Hsiao S: Amphetamine sensitization: nonassociative and associative components. Behav Neurosci 2003;117:961–969.
28.
Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. Sydney, Orlando, Academic Press, 1986.
29.
Groenewegen HJ, Berendse HW, Meredith GE, Haber SN, Voorn P, Wolters JG, Lohman AHM: Functional anatomy of the ventral, limbic system-innervated striatum; in Willner P, Scheel-Kruger J (eds): The Mesolimbic Dopamine System: From Motivation to Action. New York, Wiley, 1991, pp 19–59.
30.
White FJ: Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 1996;19:405–436.
31.
Young CD, Deutch AY: The effects of thalamic paraventricular nucleus lesions on cocaine-induced locomotor activity and sensitization. Pharmacol Biochem Behav 1998;60:753–758.
32.
Smith KS, Tindell AJ, Aldridge JW, Berridge KC: Ventral pallidum roles in reward and motivation. Behav Brain Res 2009;196:155–167.
33.
Tzschentke TM: Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 1998;56:613–672.
34.
Hiroi N, White NM: The ventral pallidum area is involved in the acquisition but not expression of the amphetamine conditioned place preference. Neurosci Lett 1993;156:9–12.
35.
Rademacher DJ, Kovacs B, Shen F, Napier TC, Meredith GE: The neural substrates of amphetamine conditioned place preference: implications for the formation of conditioned stimulus-reward associations. Eur J Neurosci 2006;24:2089–2097.
36.
Tindell AJ, Berridge KC, Aldridge JW: Ventral pallidal representation of pavlovian cues and reward: population and rate codes. J Neurosci 2004;24:1058–1069.
37.
Tindell AJ, Berridge KC, Zhang J, Pecina S, Aldridge JW: Ventral pallidal neurons code incentive motivation: amplification by mesolimbic sensitization and amphetamine. Eur J Neurosci 2005;22:2617–2634.
38.
Waraczynski M, Demco C: Lidocaine inactivation of the ventral pallidum affects responding for brain stimulation reward more than it affects the stimulation’s reward value. Behav Brain Res 2006;173:288–298.
39.
Fletcher PJ, Korth KM, Sabijan MS, DeSousa NJ: Injections of D-amphetamine into the ventral pallidum increase locomotor activity and responding for conditioned reward: a comparison with injections into the nucleus accumbens. Brain Res 1998;805:29–40.
40.
Gong W, Neill D, Justice JB Jr: Conditioned place preference and locomotor activation produced by injection of psychostimulants into ventral pallidum. Brain Res 1996;707:64–74.
41.
Hollerman JR, Grace AA: The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons. Brain Res 1990;533:203–212.
42.
Wise RA: Roles for nigrostriatal – not just mesocorticolimbic – dopamine in reward and addiction. Trends Neurosci 2009;32:517–524.
43.
Tan CO, Bullock D: A local circuit model of learned striatal and dopamine cell responses under probabilistic schedules of reward. J Neurosci 2008;28:10062–10074.
44.
Marinelli M, White FJ: Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci 2000;20:8876–8885.
45.
Nowak P, Kostrzewa RM, Kwieciński A, Bortel A, Labus L, Brus R: Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine. J Physiol Pharmacol 2005;56:325–333.
46.
Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH, Seidenbecher CI, Coenen HH, Heinze HJ, Zilles K, Duzel E, Bauer A: Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci 2008;28:14311–14319.
47.
Ostrander MM, Badiani A, Day HE, Norton CS, Watson SJ, Akil H, Robinson TE: Environmental context and drug history modulate amphetamine-induced c-fos mRNA expression in the basal ganglia, central extended amygdala, and associated limbic forebrain. Neuroscience 2003;120:551–571.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.